Artificial intelligence has begun to autonomously write prescription refills in the state of Utah, sparking concerns among medical experts and advocacy groups.
Under a pilot program using the regulatory sandbox framework, Utah's Department of Commerce partnered with Doctronic, a telehealth startup featuring an AI chatbot, to offer patients nationwide a service to refill prescriptions for common medications through an automated system.
According to a non-peer-reviewed preprint article from Doctronic, its AI diagnosed 81 percent of cases matching the diagnosis made by human clinicians. For treatment plans, the AI matched in 99 percent of cases.
For patients in Utah, Doctronic's chatbot can automatically refill prescriptions without direct oversight for $4 per service fee after verifying state residency and pulling up prescription history to offer a list of eligible medications. However, it will only be able to renew prescriptions for 190 common medications covering chronic conditions, excluding pain and ADHD medications that are injected.
Critics say the system raises concerns about safety and human oversight. Adam Oskowitz, Doctronic's co-founder and professor at the University of California, San Francisco, says his AI is designed to err on the side of caution and refer any uncertain cases to a real doctor. However, Robert Steinbrook, director of the health research group Public Citizen, describes the program as "dangerous" and urges federal regulatory agencies not to overlook autonomous medical practice.
Under a pilot program using the regulatory sandbox framework, Utah's Department of Commerce partnered with Doctronic, a telehealth startup featuring an AI chatbot, to offer patients nationwide a service to refill prescriptions for common medications through an automated system.
According to a non-peer-reviewed preprint article from Doctronic, its AI diagnosed 81 percent of cases matching the diagnosis made by human clinicians. For treatment plans, the AI matched in 99 percent of cases.
For patients in Utah, Doctronic's chatbot can automatically refill prescriptions without direct oversight for $4 per service fee after verifying state residency and pulling up prescription history to offer a list of eligible medications. However, it will only be able to renew prescriptions for 190 common medications covering chronic conditions, excluding pain and ADHD medications that are injected.
Critics say the system raises concerns about safety and human oversight. Adam Oskowitz, Doctronic's co-founder and professor at the University of California, San Francisco, says his AI is designed to err on the side of caution and refer any uncertain cases to a real doctor. However, Robert Steinbrook, director of the health research group Public Citizen, describes the program as "dangerous" and urges federal regulatory agencies not to overlook autonomous medical practice.